PIC
ELV icon

Portland Investment Counsel’s Elevance Health ELV Stock Holding History

Portland Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58,100
Closed -$17M – 59
2026
Q1 		$17M Hold
58,100
– – 5.46% 8
2025
Q4 		$20.4M Hold
58,100
– – 6.13% 6
2025
Q3 		$18.8M Hold
58,100
– – 5.14% 9
2025
Q2 		$22.6M Hold
58,100
– – 6.64% 9
2025
Q1 		$25.3M Hold
58,100
– – 7.68% 5
2024
Q4 		$21.4M Buy
+58,100
New +$24.3M 5.5% 9

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Portland Investment Counsel's ELV Position: Q2 2026 in Review

Portland Investment Counsel sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 58,100 shares — an estimated $17M sold.

Portland Investment Counsel first reported a position in ELV in Q4 2024 and held it in 6 quarters. The position peaked at $25.3M in Q1 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Portland Investment Counsel reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Portland Investment Counsel sold 58,100 Elevance Health shares in Q2 2026, an estimated $17M.
  • Portland Investment Counsel first reported a position in Elevance Health in Q4 2024 and held it in 6 quarters.
  • Portland Investment Counsel's Elevance Health position peaked at $25.3M in Q1 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Portland Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.